Gene Circuits; Cell & Gene Therapies
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
33
NCT06325748
SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 22, 2024
Completion: Aug 31, 2040
NCT06652243
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
Phase: Early Phase 1
Role: Collaborator
Start: Nov 18, 2024
Completion: Oct 31, 2027
Loading map...